Table 1: Demographics and Clinical Characteristics.
|
Parameters |
Frequency N=512 |
Percentages(%) |
||
|
AGE |
|
|
||
|
18 to 40 |
143 |
27.9 |
||
|
41 to 60 |
249 |
48.6 |
||
|
>60 |
120 |
23.5
|
||
|
GENDER |
|
|
||
|
Male |
274 |
53.5 |
||
|
Female |
238 |
46.5
|
||
|
Cancer Types Breast |
148 |
28.9 |
||
|
GENITO-URINARY Prostate (CAP) |
52 |
10.2 |
||
|
Kidney (RCC) |
80 |
15.6 |
||
|
Bladder (NHC) |
52 |
10.1 |
||
|
Testis (T) |
34 |
6.6 |
||
|
ADRENAL (AD) |
9 |
1.8 |
||
|
GASTROINTESTINAL Esophagus (ESO) |
10 |
2.0 |
||
|
Gastric (GAS) |
3 |
0.6 |
||
|
Pancreatic-Biliary (PBC) |
8 |
1.6 |
||
|
Colorectal (CRC) |
45 |
8.8 |
||
|
HAEMATOLOGY Hodgkin’s lymphoma (HL) |
15 |
2.9 |
||
|
Non-Hodgkin’s lymphoma (NHL) |
18 |
3.5 |
||
|
Multiple Myeloma (MM) |
22 |
4.3 |
||
|
MISCELLANEOUS (ONCO)
|
16 |
3.1 |
||
|
CANCER TYPES |
|
|
||
|
Solid |
456 |
89.1 |
||
|
Hematological |
56 |
10.9
|
||
|
CANCER STATUS |
|
|
||
|
On Treatment |
406 |
79.3 |
||
|
On Surveillance |
106 |
20.7
|
||
|
TREATMENT GOAL |
|
|
||
|
Curative |
386 |
75.4 |
||
|
Palliative
TREATMENT TYPE |
126 |
24.6
|
||
|
Surgery |
66 |
12.9 |
||
|
Chemotherapy |
218 |
42.6 |
||
|
Radiotherapy |
8 |
1.6 |
||
|
CCRT |
10 |
2.0 |
||
|
Hormonal Therapy |
60 |
11.7 |
||
|
Targeted therapy |
51 |
10.0
|
||
|
DID YOU GET COVID-19 INFECTION? |
|
|
||
|
YES |
36 |
7.0 |
||
|
NO |
476 |
93.0
|
||
|
DID YOU GET COVID-19 INFECTION? IF YES? [15] |
|
|
||
|
Mild |
23 |
4.5 |
||
|
Moderate |
13 |
2.5 |
||
|
Not applicable (NO infection) |
476 |
93.0
|
||
|
HAS SOMEONE IN YOUR FAMILY/FRIENDS CIRCLE
SUFFERED FROM COVID-19 INFECTION? |
||||
|
Yes |
58 |
11.3 |
||
|
No |
453 |
88.5 |
||
|
I don’t know |
1 |
0.2
|
||
|
HAS SOMEONE IN YOUR FAMILY/FRIENDS CIRCLE DIED OF
THIS INFECTION? |
||||
|
Yes |
16 |
3.1 |
||
|
No |
495 |
96.7 |
||
|
I don’t
know |
1 |
0.2
|
||
|
WILL YOU AGREE TO GET COVID-19 VACCINE? |
|
|
||
|
YES |
396 |
77.3 |
||
|
NO |
116 |
22.7 |
||